The head and neck cancer patient often presents with both protein maln
utrition and trace element deficiencies. Zinc has been found to be def
icient in many head and neck cancer patients. In this study, pretreatm
ent zinc status and nutritional status (measured by the Prognostic Nut
ritional Index [PNI]) were correlated with clinical outcomes in 47 pat
ients. The patients were followed-up for a median of 52 mo from the ti
me of enrollment. Our results showed that the tumor size and overall s
tage correlated significantly to zinc status whereas no such correlati
on was seen with PNI alcohol intake, or smoking in our subjects. The r
esults also showed that impaired zinc status was associated with an in
creased number of treatment morbidities, unplanned hospitalizations, a
nd treatment delays (P < 0.05). Nutritional status was not associated
with any studied outcome variable. The disease-free interval was highe
st for the group which had both zinc-sufficient and nutrition-sufficie
nt status. Although our data do not prove conclusively, they do sugges
t that impaired zinc status at presentation may contribute to treatmen
t morbidity, and that for an optimal mean disease-free interval, a suf
ficient zinc and nutritional status is required. Nutrition 1998;14:489
-495. (C)Elsevier Science Inc. 1998.